Hadassah

Hadassah Receives $6.5 Million Grant to Create Translational Medicine Institute

Monday, Feb 2 2015

Left to right: Mark Addleman, Executive Director, Hadassah UK; Guilda Shamash, Past Chair, Hadassah UK; Melissa Kaplan, Director, Hadassah International; Sir Ian Gainsford, Hadassah UK Advisory Committee and Hadassah International Board of Directors; Prof. Tamar Peretz, Interim Director, HMO; Dr. Linda Greenwall, Hadassah UK Trustee; and Jean Jacque Roboh, Hadassah UK Trustee.

Hadassah is delighted to start the new year with the announcement of a $6,500,000 grant to the Hadassah Medical Organization (HMO) from the Wohl Legacy Foundation in the UK to create the Wohl Institute for Translational Medical Researchone of the foundation's medicine and arts 50th anniversary celebratory grants, commemorating 50 years of giving.

Prof. Tamar Peretz, Acting Director General of HMO, who traveled to London to participate in the awards ceremony, noted that translational medicine brings the benefits of science back to the patient, with better technology to create improved infrastructure. In contrast to 15 years ago when science was undertaken only in the university setting, with translational medicine, scientific and medical needs can be defined at the individual patient level, then transferred from the patient to the laboratory to find a solution. The research results then flow back to the patient. This process allows a quicker transfer of knowledge and clinical application, resulting in better quality patient care.

The new Wohl Centre for Translational Medicine at Hadassah will look particularly into how diseases begin and progress, the development of drugs for specific diseases, and how individual patients benefit from different treatments and drug regimens. Physician/researchers will especially focus their work on cancers, multi-genes, Parkinson's, ALS, and other degenerative diseases.

The trustees of The Wohl Legacy Foundation believe that investing in translational medicine is vital to developing the most effective therapies for these complex diseases. This new Institute at Hadassah will bolster the hospital's team of clinicians and biomedical researchers with access to open laboratory space and cutting-edge scientific technology. It is their belief that Hadassah will provide a dramatic stimulus to translational medicine, and will help meet global clinical needs. The award was given to Hadassah because its history is one of scientific development and it continues to generate the highest number of research papers emanating from one institution in Israel.

Maurice Wohl, a rabbi's son, was born and raised in London. His faith and upbringing played a huge part in the evolution of his philanthropy. Prior to Vivienne's death from cancer in 2005 at the age of 59, they decided to establish the Maurice and Vivienne Wohl Philanthropic Foundation as a reflection of their lifetime of philanthropic activity. Maurice died in 2007, at age 90. He was buried in Jerusalem next to his beloved wife.

At the awards ceremony on January 29th, along with the announcements of the grant recipients, the Wohl Lecture was delivered by His Excellency Matthew Gould, Britain's Ambassador to Israel. In his remarks, the Ambassador said: "It is a real honor to give the Wohl lecture in the philanthropy's 50th Anniversary year. I feel passionately that the Jewish community here can have a huge and positive impact on relations between Britain and Israel. Jewish philanthropy tied together with Israeli creativity has achieved amazing things in Israel, and is still doing so. Maurice and Vivienne Wohl were models for giving that makes a difference.”

Comments

From: Sherri on March 16, 2015
Great news, I am so proud of Hadassah and the work we do!
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Sep 23 2016

2016 Graduates from 19 Countries Celebrate Hadassah’s IMPH Program

Singing "It's a Wonderful Country" in Hebrew, wearing their native dress, the members of the 41st International Master of Public Health (IMPH) program of the Hadassah-Hebrew University Braun School of Public Health and Community Medicine celebrated their graduation.

READ MORE ›
alt_text

Monday, Sep 19 2016

Hadassah Hospital Treats Terror Victims After Stabbing Attacks

This last week has brought a burst of terror attacks.

READ MORE ›
alt_text

Thursday, Sep 15 2016

“Stunning Results” Continue with Hadassah’s Stem Cell Treatment to Reverse MS

The Hadassah Medical Center is continuing to receive positive findings with its Phase II clinical trial using its unique stem cell approach to stop the progression and reversing the disabilities of multiple sclerosis.

READ MORE ›
alt_text

Thursday, Sep 15 2016

2012 Hadassah Stage-Four Melanoma Patient Thankfully Healthy

"Doctors in Florida who pronounced me ‘soon-dead’ can't believe that I'm healthy today,” said Hadassah melanoma patient Stewart Greenberg.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More